Investing Profile

Beth Seidenberg

VCInvestor
General Partner at Kleiner Perkins
westlakebio.com/team/beth-sei...San Francisco, California
Photo of Beth Seidenberg, General Partner at Kleiner Perkins

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
NewCo Network
1581 CONNECTIONS
CILA THERAPEUTICS Network
87 CONNECTIONS
Kleiner Perkins Caufield & Byers Network
40 CONNECTIONS
Kleiner Perkins Network
38 CONNECTIONS
Amgen Network
17 CONNECTIONS
cb
Kleiner Perkins General Partner
$2.0M - $50.0M
$25.0M
1
750M
CompanyStageDateRound SizeTotal Raised
Practice Fusion
Series DSep 2013$85M
$85M
Co-investors: Aydin Senkut (Felicis Ventures), Gary Little (Canvas Ventures), Stuart Peterson (Artis Ventures (AV)), Rebecca Lynn (Morgenthaler Ventures)
General Partner Kleiner Perkins2005 - Present
General Partner Kleiner Perkins Caufield & ByersPresent
Senior Vice President AmgenPresent
Senior Vice President, Global Development Bristol Myers SquibbPresent
Senior Vice President, Clinical Development & Life Cycle Management Bristol Myers SquibbPresent
Vice President, Clinical Immunology/Pulmonary/Dermatology Bristol Myers SquibbPresent
Co-founding Managing Director at Westlake Village BioPartners Westlake Village BioPartners®Present
Vice President, Pulmonary-Immunology MerckPresent
Executive Director MerckPresent
Senior Director MerckPresent
Director, Clinical Pharmacology MerckPresent
Associate Director, Clinical Pharmacology MerckPresent
General Partner NewCoPresent
Co-founding Managing Director at Westlake Village BioPartners Westlake BioPartners®Present
General Partner CILA THERAPEUTICSPresent
Senior Vice President, Clinical Development & Life Cycle Management Bristol Myers SquibbPresent